These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7075119)

  • 1. Amiloride in Bartter's syndrome.
    Griffing GT; Komanicky P; Aurecchia SA; Sindler BH; Melby JC
    Clin Pharmacol Ther; 1982 Jun; 31(6):713-8. PubMed ID: 7075119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiloride in primary hyperaldosteronism.
    Griffing GT; Cole AG; Aurecchia SA; Sindler BH; Komanicky P; Melby JC
    Clin Pharmacol Ther; 1982 Jan; 31(1):56-61. PubMed ID: 7053305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Bartter's syndrome in pregnancy treated by amiloride.
    Deruelle P; Dufour P; Magnenant E; Courouble N; Puech F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):106-7. PubMed ID: 15223177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.
    Blanchard A; Vargas-Poussou R; Vallet M; Caumont-Prim A; Allard J; Desport E; Dubourg L; Monge M; Bergerot D; Baron S; Essig M; Bridoux F; Tack I; Azizi M
    J Am Soc Nephrol; 2015 Feb; 26(2):468-75. PubMed ID: 25012174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
    Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
    Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium-sparing effect of amiloride in a diuretic factorial study in man.
    Schapel GJ; Edwards DG; Robinson J
    Clin Exp Pharmacol Physiol; 1975; 2(4):277-87. PubMed ID: 1097143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total exchangeable potassium in response to amiloride.
    Pearce VR; Antcliff AC; Beevers DG; Hamilton M
    Postgrad Med J; 1978 Aug; 54(634):533-7. PubMed ID: 733684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.
    Ram CV; Holland OB; Kaplan NM
    J Clin Pharmacol; 1981; 21(11):484-7. PubMed ID: 7334141
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme).
    Macfie HL; Colvin CL; Anderson PO
    Drug Intell Clin Pharm; 1981 Feb; 15(2):94-8. PubMed ID: 7274028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride--a potassium-sparing diuretic.
    Med Lett Drugs Ther; 1981 Dec; 23(26):109-10. PubMed ID: 7031456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A; Radó J
    Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome].
    Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B
    Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
    Vidt DG
    Pharmacotherapy; 1981; 1(3):179-87. PubMed ID: 6927605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bartter's syndrome. A condition with chronic hypokalemia].
    Brix TH; Djurhuus MS; Klitgaard NA
    Ugeskr Laeger; 1996 Sep; 158(38):5277-80. PubMed ID: 8966774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiloride hydrochloride combined with hydrochlorothiazide in the control of hypertension and plasma potassium levels.
    Antcliff AC; Hamilton M; Beevers DG; Harpur JE
    Br J Clin Pract; 1972 Sep; 26(9):413-6. PubMed ID: 5080334
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic low serum potassium levels in potassium losing kidney by amiloride (author's transl)].
    Kaiser I
    Med Klin; 1974 Jan; 69(4):156-8. PubMed ID: 4814434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.